Arbutus Biopharma Corp (NASDAQ:ABUS)

3.93
Delayed Data
As of Dec 03
 -0.01 / -0.25%
Today’s Change
0.88
Today|||52-Week Range
9.02
+41.37%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close3.95
Today’s open4.03
Day’s range3.91 - 4.09
Volume2,122,774
Average volume (3 months)2,856,854
Market cap$368.5M
Data as of 3:59pm ET, 12/03/2020

Growth & Valuation

Earnings growth (last year)-137.84%
Earnings growth (this year)+66.23%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+1.11%
P/E ratioNM
Price/Sales26.40
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CTMXCytomX Therapeutics ...-0.15-2.02%
GMDAGamida Cell Ltd-0.19-2.80%
FULCFulcrum Therapeutics...+0.11+0.94%
CNCEConcert Pharmaceutic...-0.59-5.28%
Data as of 3:59pm ET, 12/03/2020

Financials

Next reporting dateMarch 11, 2021
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$6.0M
Annual profit (last year)-$153.7M
Net profit margin-2,557.36%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Warminster, Pennsylvania

Forecasts